Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer

Practical Radiation Oncology

Volumn 5, Issue 6, 2015, Pages e659-e664

  Paravati, Anthony J ^a   Hawkins, Peter G ^a   Martin, Amanda N ^b   Mansy, Gina ^a   Rahn, Doug A ^a   Advani, Sunil J ^a   Hoisak, Jeremy ^a   Dragojevic, Irena ^a   Martin, Peter J ^c   Miller, Charles J ^c   Sanghvi, Parag ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; RETINOIC ACID; TRETINOIN A; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ARTICLE; BASAL CELL CARCINOMA; BRACHYTHERAPY; COHORT ANALYSIS; COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS; COSMETIC RATING SCALE; DISEASE SEVERITY; ELASTOSIS; ELECTRONIC BRACHYTHERAPY; FEMALE; FOLLOW UP; HUMAN; HYPOPIGMENTATION; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RATING SCALE; RECURRENCE RISK; RETROSPECTIVE STUDY; SKIN CARCINOMA; TELANGIECTASIA; ULCER; ADULT; BODY IMAGE; CANCER STAGING; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; ESTHETICS; PROGNOSIS; RADIOTHERAPY DOSAGE; SKIN NEOPLASMS;

ADULT; BODY IMAGE; BRACHYTHERAPY; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; ESTHETICS; HUMANS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84946496377     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2015.07.002     Document Type: Article

References (36)

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015, 65:5-29.
2. Torre L.A., Bray F., Siegel R.L., et al. Global cancer statistics, 2012. CA Cancer J Clin 2015, 65:87-108.
3. Rogers H.W., Weinstock M.A., Harris A.R., et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010, 146:283-287.
4. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012, 166:1069-1080.
5. Lewis K.G., Weinstock M.A. Nonmelanoma skin cancer mortality (1988-2000): The Rhode Island follow-back study. Arch Dermatol 2004, 140:837-842.
6. Housman T.S., Feldman S.R., Williford P.M., et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003, 48:425-429.
7. Bickers D.R., Lim H.W., Margolis D., et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for investigative Dermatology. J Am Acad Dermatol 2006, 55:490-500.
8. Whelan C.S., Deckers P.J. Electrocoagulation for skin cancer: An old oncologic tool revisited. Cancer 1981, 47:2280-2287.
9. Silverman M.K., Kopf A.W., Grin C.M., et al. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol 1991, 17:720-726.
10. Kuflik E.G. Cryosurgery for cutaneous malignancy. An update. Dermatol Surg 1997, 23:1081-1087.
11. Love W.E., Bernhard J.D., Bordeaux J.S. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: A systematic review. Arch Dermatol 2009, 145:1431-1438.
12. Silverman M.K., Kopf A.W., Bart R.S., et al. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992, 18:471-476.
13. Lansbury L., Bath-Hextall F., Perkins W., et al. Interventions for non-metastatic squamous cell carcinoma of the skin: Systematic review and pooled analysis of observational studies. BMJ 2013, 347:f6153.
14. Chren M.M., Torres J.S., Stuart S.E., et al. Recurrence after treatment of nonmelanoma skin cancer: A prospective cohort study. Arch Dermatol 2011, 147:540-546.
15. Muller F.M., Dawe R.S., Moseley H., et al. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: Tissue-sparing outcome. Dermatol Surg 2009, 35:1349-1354.
16. Smeets N.W., Krekels G.A., Ostertag J.U., et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: Randomised controlled trial. Lancet 2004, 364:1766-1772.
17. Connolly S.M., Baker D.R., Coldiron B.M., et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: A report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol 2012, 67:531-550.
18. Avril M.F., Auperin A., Margulis A., et al. Basal cell carcinoma of the face: Surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997, 76:100-106.
19. Petit J.Y., Avril M.F., Margulis A., et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000, 105:2544-2551.
20. Lovett R.D., Perez C.A., Shapiro S.J., et al. External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 1990, 19:235-242.
21. Silva J.J., Tsang R.W., Panzarella T., et al. Results of radiotherapy for epithelial skin cancer of the pinna: The Princess Margaret Hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 2000, 47:451-459.
22. Locke J., Karimpour S., Young G., et al. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 2001, 51:748-755.
23. Kwan W., Wilson D., Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 2004, 60:406-411.
24. Caccialanza M., Piccinno R., Kolesnikova L., et al. Radiotherapy of skin carcinomas of the pinna: A study of 115 lesions in 108 patients. Int J Dermatol 2005, 44:513-517.
25. Chan S., Dhadda A.S., Swindell R. Single fraction radiotherapy for small superficial carcinoma of the skin. Clin Oncol 2007, 19:256-259.
26. Kohler-Brock A., Prager W., Pohlmann S., et al. The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig applicator). Strahlenther Onkol 1999, 175:170-174.
27. Guix B., Finestres F., Tello J., et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000, 47:95-102.
28. Petrovich Z., Parker R.G., Luxton G., et al. Carcinoma of the lip and selected sites of head and neck skin. A clinical study of 896 patients. Radiother Oncol 1987, 8:11-17.
29. Petsuksiri J., Frank S.J., Garden A.S., et al. Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer 2008, 112:111-118.
30. Beitsch P.D., Patel R.R., Lorenzetti J.D., et al. Post-surgical treatment of early-stage breast cancer with electronic brachytherapy: An intersociety, multicenter brachytherapy trial. Onco Targets Ther 2010, 3:211-218.
31. Dickler A., Puthawala M.Y., Thropay J.P., et al. Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer. Radiat Oncol 2010, 5:67.
32. Bhatnagar A., Loper A. The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer. Radiat Oncol 2010, 5:87.
33. Bhatnagar A. Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year. Brachytherapy 2013, 12:134-140.
34. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346.
35. Perez-Calatayud J., Granero D., Ballester F., et al. A dosimetric study of Leipzig applicators. Int J Radiat Oncol Biol Phys 2005, 62:579-584.
36. Niu H., Hsi W.C., Chu J.C., et al. Dosimetric characteristics of the Leipzig surface applicators used in the high dose rate brachy radiotherapy. Med Phys 2004, 31:3372-3377.